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http://dx.doi.org/10.1016/j.hkjn.201Summary Objective: In this study we investigated the effect of peritoneal dialysis (PD) on
some antioxidant markers and lipid peroxidation.
Methods: The levels of malondialdehyde (MDA), erythrocyte superoxide dismutase (SOD),
glutathione peroxidase (GPx), vitamins A, E, and C, and total antioxidant capacity (TAC) were
determined in 23 chronic ambulatory PD patients and 34 healthy controls.
Results: The results showed MDA level in patients were not significantly different from those in
controls. Erythrocyte SOD and GPX activities and vitamin C level were significantly decreased
in the chronic ambulatory PD group (p < 0.0001), while the levels of TAC (p < 0.01), uric acid,
and vitamins A (p < 0.0001) and E (p > 0.05) were enhanced with respect to the control group.
Conclusions: The findings suggest that despite slightly increased MDA level, patients on PD are
exposed to oxidative stress, as evidenced by the decreased levels of SOD, GPx, and vitamin C.
Depletion of these antioxidants may contribute to accelerated atherogenesis in these patients.
背景: 本研究旨在調查腹膜透析對抗氧化指標及脂質過氧化的影響。
方法: 我們分別在23位腹膜透析患者(CAPD組)及34位健康人士(對照組)間，測量了malondialde-
hyde (MDA)、紅血球superoxide dismutase (SOD)與glutathione peroxidase (GPx)(酵素指標)、
vitamin A、E、與C (非酵素指標)、及總抗氧化能力(TAC)水平。
結果: 結果顯示，相比於對照組，CAPD組病人的MDA水平並無明顯差異，但具明顯較低的SOD
與GPx活動及v i tamin C數值 (P <0.0001)。然而與對照組相比，CAPD組具較高的TAC
(P < 0.01)、uric acid、及vitamin A (P<0.0001)與vitamin E (P>0.05)數值。
結論: 本研究發現，即使具稍高的MDA數值，腹膜透析患者暴露於較高的氧化壓力中(反映於較低
的SOD、GPx及vitamin C水平)。相關抗氧化物的損耗可能加速這些病人的動脈粥樣化進程。of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
ail.com (F. Montazerifar).
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were heparin for measurement of enzymatic antioxidants,End stage renal disease patients are reported to have high
mortality unless renal replacement therapy is administrated
in the form of hemodialysis, peritoneal dialysis or kidney
transplantation.1 Peritoneal dialysis (PD) is an established
supportive treatment; almost 15% of patients on dialysis in
the developed world and half the dialysis patients in the UK
are treated in this way2,3 but PD therapy duration is limited
because of progressive atrophy of the peritoneum within
a relatively short period.4 Oxidative stress is a common
phenomenon in end stage renal disease patients treated by
dialysis.5e7 Patients on PD are perhaps at particular oxida-
tive risk due to decreased antioxidant levels and increased
production of reactive oxygen species.2,6 On the other hand,
increased oxidative stress has been suggested as one
possible mechanism of peritoneum structural and functional
changes resulting from prolonged exposure to PD solutions
containing high concentrations of glucose, obstruction of
catheter and high incidence of peritonitis.8e10 The most
important antioxidants that protect from oxidant damage
include: erythrocyte superoxide dismutase (SOD) and
glutathione peroxidase (GPx); and nonenzymatic antioxi-
dants vitamins A, C, and E.2,5,6,11,12 The importance of
oxidative stress in the pathogenesis of cardiovascular
complications has recently been emphasized.6,10,12,13 Thus,
the present study was undertaken to investigate some anti-
oxidantmarkers and potential effects PD on oxidative stress.Patients and methods
Patients
Twenty-three patients (12 female, age 26e70 years, mean
46.1 14.5 years) on continuous ambulatory PD (CAPD) were
enrolled from the center of hemodialysis at Khatam-Al-Anbia
Hospital, Zahedan Medical University, Iran. They received
three or four daily exchanges of 2 L of peritoneal dialysis
solution with either 1.5% or 2.5% glucose. Duration of dialysis
was 3 to 48 months (mean 24.6 months). Dialysis adequacy
was defined by Kt/V of 1.2 or greater. The causes of end
stage renal failure included diabetes (nZ 5), blood pressure
(n Z 7), diabetes and blood pressure (n Z 2), glomerulo-
nephritis (n Z 3), lupus erythematosus (n Z 1), polycystic
kidney (nZ 1) and unknown (nZ 4). They had no history of
cardiovascular diseases or recent occurrence of peritonitis.
None of them took antioxidant supplements and none were
smokers. Thirty-four aged-matched healthy individuals (18
female, age 25e72 years, mean 49.4  15 years) as control
were included in this study. They had no medical problems,
no cigarette smoking, and were on neither lipid lowering
drugs nor vitamin supplements. The protocol of study
was approved by the ethical committee of Zahedan Univer-
sity of Medical Sciences and informed consent was obtained
from all patients and healthy individuals.
Biochemical analysis
After an overnight fast, venous blood samples were
collected from patients and healthy individuals in tubeswith and without anticoagulant. The anticoagulants used
vitamin C, total antioxidant capacity (TAC), and malon-
dialdehyde (MDA); and ethylenediaminetetra-acetic acid
for hemoglobin measurement. Blood samples were pro-
tected from light by aluminum foil and centrifuged imme-
diately at 3000  g for 10 minutes and plasma or serum
collected respectively. All samples were aliquoted and
stored in a freezer at 80C until analysis. Serum samples
were used for biochemical analysis (blood urea nitrogen,
uric acid, creatinine, total protein, albumin) using
commercial colorimetric assay kits (Parsazmun company,
Tehran, Iran). Hemoglobin was measured using a Sysmex
KX-21 (Sysmex, Kobe, Japan). Low-density lipoprotein
values were calculated by the Friedwald formula.14
Antioxidants assay
Plasma total antioxidant status was determined by the ferric
reducing/antioxidant power assay at 593 nmaccording to the
method of Benzie and Strain.14,15 Erythrocyte SOD and GPx
activity were measured using commercial colorimetric assay
kit (Randox, Crumlin, County Antrim, UK) as described
previously.11,15 Serum vitamin A and E were extracted with
hexane and measured by using high pressure liquid chroma-
tography with absorption at 325 nm and 292 nm, respec-
tively.11,15 Plasma total vitamin C concentration was
measured spectrophotometerically by the 2,4 dini-
trophenylhydrazine method.11,15 Plasma MDA level was
assayed as the end product of lipid proxidation by thio-
barbituric acid method at 530 nm.11,15
Statistical analysis
Data were analyzed using SPSS 15.0 for Windows (SPSS,
Chicago, IL, USA) and are expressed as mean  SD. The
different variables between PD patients and control
subjects were compared using independent samples
Student t test. The relationship between variables was
checked by Pearson’s correlation coefficient. A p-value
<0.05 was considered significant.
Results
Clinical and biochemical parameters
As shown in Table 1, creatinine, blood urea nitrogen, and
uric acid concentrations were higher in PD patients
compared to age-matched healthy controls. Cholesterol
and high-density lipoprotein concentrations were lower,
and triglyceride and low-density lipoprotein concentrations
higher in patients than in controls. Patients on CAPD
showed markedly lower hemoglobin and lower total protein
and albumin concentrations than those in controls.
Biomarkers of oxidative stress
According to Table 2, MDA levels in patients were not
significantly different from those in controls. Significantly
higher levels of TAC and vitamin A of the CAPD patients
Table 1 Characteristics of peritoneal dialysis (PD) patients and control subjects.
PD patients (n Z 23) Controls (n Z 34) p
Age (y) 46.2  14.5 49.4  15.7 NS
Sex F/M: 12/11 F/M: 18/16
Duration of PD (mo) 20  16.1(3-48) e
BMI (kg/m2) 22.9  3.5 25.6  4.7 <0.05
Kt/V 2.01  0.74
RRF (mL/min) 2.5  1.7
Blood pressure (mmHg)
Systolic 141.1  23.4 113.1  14.1 <0.0001
Diastolic 83.9  9.4 72.2  10.2 <0.0001
Creatinine (mg/dL) 7.32  2.6 0.87  0.18 <0.0001
BUN (mg/dL) 65.4  30.3 13.1  4 <0.0001
Uric acid (mg/dL) 7.4  1.8 5.3  1.5 <0.0001
Cholesterol (mg/dL) 172.8  31 218.6  58.1 <0.01
LDL (mg/dL) 141  65.1 94.5  26.8 <0.01
HDL (mg/dL) 41.1  13.2 54.2  11.6 <0.0001
Triglycerides (mg/dL) 182.3  78.1 112.4  47.2 <0.001
Albumin (g/L) 3.1  0.48 4.6  0.5 <0.001
Total protein (g/L) 5.2  0.27 6.9  0.4 <0.001
Hemoglobin (g/dL) 10.1  2 14.8  1.5 <0.001
Values are mean  SD.
BUN Z blood urea nitrogen; BMI Z body mass index; HDL Z high-density lipoprotein; LDL Z low-density lipoprotein;
NS Z nonsignificant; RRF Z residual renal function.
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and p < 0.0001, p < 0.0001, respectively). No significant
difference was shown in the levels of serum vitamin E in
CAPD patients and the control group, while the levels of
plasma vitamin C (p < 0.0001) and erythrocyte activities of
SOD and GPx (p < 0.0001) were markedly lower in CAPD
patients than in controls. A significant correlation was
observed between TAC and uric acid (rZ 0.65, p < 0.001),
but there was no correlation between MDA or TAC with
other clinical parameters (blood pressure, serum albumin,
and total protein). There were also an nonsignificant
negative correlation between MDA with vitamin C
(rZ 0.29, p > 0.05) and vitamin E (rZ 0.16, p > 0.05).
Discussion
As previously reported, dialysis treatment contributes to
oxidative stress and to modifications of the balance
between antioxidant and oxidant-generating systems thatTable 2 Oxidant and antioxidant status of PD patients and con
PD patients (n Z 23)
MDA (mmol/L) 0.132  0.06
TAC (mmol/L) 969.4  237.1
SOD (U/g Hb) 1173.2  362.8
GPx (U/g Hb) 16.3  3.9
Vitamin A (mg/dL) 136.2  54.2
Vitamin E (mg/dL) 752.7  205.3
Vitamin C (mg/dL) 0.69  0.25
Values are mean  SD.
GPx Z glutathione peroxidase; Hb Z hemoglobin; MDA Z malond
TAC Z total antioxidant capacity.could be a primary event triggering the atherogenic
complications in uremic patients.11,13 In CAPD patients,
prolonged exposure to conventional PD fluid can lead to
structural and functional alterations of the peritoneal
membrane and enhanced oxidative stress.8,9 Our study
showed that in CAPD patients, the high levels of MDA were
no different from those observed in the healthy controls, in
conflict with other studies.16e19 Ozden et al13 also showed
that CAPD patients have elevated MDA, but at a lower level
than hemodialysis patients; this suggests that uremic
patients maintenance on dialysis are at a high risk of
oxidative stress, which worsens with hemodialysis treat-
ment. MDA is a good marker of lipid proxidation in biolog-
ical system. Increase in the MDA levels is a reflection of
either the overproduction of reactive oxygen species, and/
or a slower clearance of MDA with progressive renal
failure.13
With regard to the nonsignificant elevated MDA level in
the present study, it seems CAPD treatment by itself doestrol subjects.
Controls (n Z 34) p
0.112  0.02 NS
803  184 <0.01
2316.5  493.1 <0.0001
30.5  8.2 <0.0001
58.3  11.4 <0.0001
692.1  180.5 NS
1.13  0.38 <0.0001
ialdehyde; NS Z nonsignificant; SOD Z superoxide dismutase;
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enzymatic antioxidant systems are low, it may worsen this
condition, as observed in the present study. The signifi-
cantly decreased erythrocyte SOD activity in this study in
comparison with control values is in agreement with data
reported by Taylor et al16 and Mydlı´k et al20 but not with
Bonnefont-Rousselo et al.6 We also found a significant
decline in erythrocyte GPx activity compared to controls
that is in agreement with several studies,6,13,20 while
Yoshimura et al21 did not find any difference in erythrocyte
GPx activity. Our findings indicate that the erythrocyte GPx
activity could be related to renal function, as damage of
GPx activity has been observed in early stages of renal
failure.6 Glutathione peroxidases are antioxidant enzymes
that can detoxify hydrogen peroxide and lipid peroxides in
the presence of reduced glutathione.13
No deficiency in the two lipid-soluble antioxidants
(vitamin A and E), which are not filtered through the
membrane,22 was found. Even a significant increase in the
levels of serum vitamin A was observed when compared
with the healthy controls that is in agreement with some
earlier studies.2,6 Accumulation of retinol in CRF patients
can be related to the defect in retinol binding protein
metabolism (vitamin A carrier).6,11 On the other hand,
there was no significant difference in the serum levels of
vitamin E in CAPD patients with respect to controls and
were within the normal range as shown by Bonnefont-
Rousselo et al.6 It has been also reported that because of
utilization of much more artificial materials in HD proce-
dure, vitamin E levels were lower in hemodialysis patients
than in CAPD patients.5
Plasma vitamin C concentrations, unlike the lipophilic
antioxidants were found to be markedly lower than in
controls. Our findings are in accordance with the reports by
Zhang23 and Finkelstein et al,24 but not with Mydlı´k et al.20
Low plasma concentration of vitamin C in dialysis patients
can be due to inadequate intake of fruits and vegetables,
loss during the dialysis process, reduced tubular reabsorp-
tion, impaired metabolism, and/or utilization of vitamin C
in regenerating or sparing vitamin E from tocopheroxyl
radicals.11,22,23
In the present study, plasma levels of TAC were shown to
be high in CAPD patients compared with the control group,
similar to earlier studies.19,25 TAC is a valuable tool for
assessment of the antioxidant capacity of all antioxidants in
a biological system.14,26 A possible explanation for the
enhancement of TAC levels in these patients is that vitamin
E concentrations remained stable and vitamin A and uric
acid levels were markedly increased. It has been reported
that the presence of uric acid strongly affects the TAC
level,26 as, in the present, study a significant correlation
was observed between TAC and uric acid (r Z 0.65,
p < 0.001). Despite the fact that uric acid has antioxidant
properties capable of scavenging oxygen free radical, but
cannot be considered solely to protect against the lipid
peroxidation, as there are other endogenous compounds
contributing to it.14,22
In conclusion, the findings suggest that, although
elevated plasma levels of MDA (an end product of the
peroxidation of polyunsaturated fatty acids) was no
different from that observed in the healthy controls, the
existence of oxidative stress was proved in PD patients, asevidenced by the decline in the activity of the enzymatic
antioxidant defense system (SOD and GPx), and plasma
vitamin C levels. Depletion of these antioxidants may
contribute to accelerated atherogenesis in these patients.Financial support
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